These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 36640916)

  • 1. Enhancement of mitochondrial function using NO releasing nanoparticles; a potential approach for therapy of Alzheimer's disease.
    Samir M; Abdelkader RM; Boushehri MS; Mansour S; Lamprecht A; Tammam SN
    Eur J Pharm Biopharm; 2023 Mar; 184():16-24. PubMed ID: 36640916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
    Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
    Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of PLGA-functionalized quercetin nanoparticles for potential use in Alzheimer's disease.
    Sun D; Li N; Zhang W; Zhao Z; Mou Z; Huang D; Liu J; Wang W
    Colloids Surf B Biointerfaces; 2016 Dec; 148():116-129. PubMed ID: 27591943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ
    Amin FU; Shah SA; Badshah H; Khan M; Kim MO
    J Nanobiotechnology; 2017 Feb; 15(1):12. PubMed ID: 28173812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease.
    Mathew A; Fukuda T; Nagaoka Y; Hasumura T; Morimoto H; Yoshida Y; Maekawa T; Venugopal K; Kumar DS
    PLoS One; 2012; 7(3):e32616. PubMed ID: 22403681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of surface-engineered PLGA nanoparticulate-delivery system of Tet1-conjugated nattokinase enzyme for inhibition of Aβ
    Bhatt PC; Verma A; Al-Abbasi FA; Anwar F; Kumar V; Panda BP
    Int J Nanomedicine; 2017; 12():8749-8768. PubMed ID: 29263666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-coated poly(lactic-co-glycolic) acid nanoparticles as an efficient delivery system for Newcastle disease virus DNA vaccine.
    Zhao K; Zhang Y; Zhang X; Shi C; Wang X; Wang X; Jin Z; Cui S
    Int J Nanomedicine; 2014; 9():4609-19. PubMed ID: 25356070
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhang L; Yang S; Wong LR; Xie H; Ho PC
    Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of berberine chloride for an efficient suppression of Ehrlich ascites tumors.
    Bhatnagar P; Kumari M; Pahuja R; Pant AB; Shukla Y; Kumar P; Gupta KC
    Drug Deliv Transl Res; 2018 Jun; 8(3):565-579. PubMed ID: 29441466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memantine loaded PLGA PEGylated nanoparticles for Alzheimer's disease: in vitro and in vivo characterization.
    Sánchez-López E; Ettcheto M; Egea MA; Espina M; Cano A; Calpena AC; Camins A; Carmona N; Silva AM; Souto EB; García ML
    J Nanobiotechnology; 2018 Mar; 16(1):32. PubMed ID: 29587747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
    Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q
    ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnetic targeting of paclitaxel-loaded poly(lactic-
    Ganipineni LP; Ucakar B; Joudiou N; Bianco J; Danhier P; Zhao M; Bastiancich C; Gallez B; Danhier F; Préat V
    Int J Nanomedicine; 2018; 13():4509-4521. PubMed ID: 30127603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells loaded with paclitaxel-poly(lactic-
    Wang X; Gao J; Ouyang X; Wang J; Sun X; Lv Y
    Int J Nanomedicine; 2018; 13():5231-5248. PubMed ID: 30237710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled Nitric Oxide Release Using Poly(lactic-co-glycolic acid) Nanoparticles for Anti-Inflammatory Effects.
    Oh Y; Jeong H; Lim S; Hong J
    Biomacromolecules; 2020 Dec; 21(12):4972-4979. PubMed ID: 33147008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular drug delivery by poly(lactic-co-glycolic acid) nanoparticles, revisited.
    Xu P; Gullotti E; Tong L; Highley CB; Errabelli DR; Hasan T; Cheng JX; Kohane DS; Yeo Y
    Mol Pharm; 2009; 6(1):190-201. PubMed ID: 19035785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma.
    Ma C; Wei T; Hua Y; Wang Z; Zhang L
    Int J Nanomedicine; 2021; 16():4495-4513. PubMed ID: 34239301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of siRNA-encapsulated PLGA nanoparticles for sustained release of siRNA and evaluation of encapsulation efficiency.
    Pantazis P; Dimas K; Wyche JH; Anant S; Houchen CW; Panyam J; Ramanujam RP
    Methods Mol Biol; 2012; 906():311-9. PubMed ID: 22791444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pronounced induction of endoplasmic reticulum stress and tumor suppression by surfactant-free poly(lactic-co-glycolic acid) nanoparticles via modulation of the PI3K signaling pathway.
    Hou CC; Tsai TL; Su WP; Hsieh HP; Yeh CS; Shieh DB; Su WC
    Int J Nanomedicine; 2013; 8():2689-707. PubMed ID: 23940416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.